Astrazeneca adjusts the information on the effectiveness of the corona vaccine. Millions of vaccine doses are discovered in a warehouse in Italy. The news ticker.
- Germany and other countries had Corona– Vaccinations with the Astrazeneca–vaccine temporarily suspended.
- In a warehouse in Italy Authorities discover around 30 million doses of the Corona vaccine of Astrazeneca.
- Corona-News: New data show that the vaccine is less effective than previously stated.
<<< update ticker >>>
Update from Thursday, March 25th, 2021, 9.45 a.m .: New data from research results show that the Corona vaccine of Astrazeneca is less effective than previously thought. A report from Mirrors According to the British-Swedish pharmaceutical company corrected the information slightly downwards: Before one Corona infection with symptoms protect the vaccine to 76 percent instead of 79 percent.
As the company reports, this value is 85 percent for over 65-year-olds. Accordingly, fewer diseases occurred among the elderly in a vaccinated group of test persons. Despite everything, the vaccine is against severe Covid-19 courses 100 percent effective.
Astrazeneca vaccine: found in Italy – 30 million vaccine doses in storage
+++ 3.47 p.m .: The pharmaceutical company Astrazeneca According to media reports, around 30 million cans of his Corona vaccine store in Italy. Like the Italian newspaper The print reported, be that Vaccine discovered by Italian authorities in a warehouse at a bottling plant near Rome. The pharmaceutical company has the stock of Vaccination doses not disclosed in Italy. Of the vaccine reportedly packaged for export.
The numerous Vaccination doses are for export to Great Britain definitely, reports the Italian newspaper The print continue. The news agency dpa According to Brussels, the report has been confirmed. Although Astrazeneca According to the contract with the European Commission, around 100 million cans should have been delivered by the end of March, only around 30 million cans have so far arrived in the EU countries.
Neither Astrazeneca the EU Commission have yet to comment on the report. Only recently the EU Commission threatened the export of Corona vaccines stop if the group does not meet its delivery obligations.
Astrazeneca vaccine is re-vaccinated – and remains controversial
Update from Wednesday, March 24th, 2021, 10:58 a.m .: Of the Corona vaccine from Astrazeneca is still under criticism. Alone in Germany are now 16 cases of Blood clots in the brain after one Astrazeneca-Vaccination known, reports the Berlin newspaper on Wednesday (March 24th, 2021). Like a spokeswoman for vaccines Paul Ehrlich Institute (PEI) in Langen on Tuesday (23.03.2021) of the news agency AFP reported, all except one report concerned women aged 20 to 63 years. In four cases the so-called cerebral vein thrombosis was fatal. In Germany, a total of more than 1.8 million first doses and 269 second doses of Astrazeneca vaccine were vaccinated (as of Monday, March 22, 2021).
Of the Corona vaccine from Astrazeneca remains controversial due to reports of possible serious side effects. In the meantime, many countries had the Vaccinations with the Vaccine the Swedish-British manufacturer stopped, so too Germany. Reports of serious incidents such as Blood clot and Bleedingthat occurred after vaccination. According to a positive assessment of the European Medicines Agency EMA However, the federal government decided to remove the vaccine from Astrazeneca to further inoculate in Germany. However, there are still reports of side effects.
Astrazeneca vaccine: researchers do not show an increased risk of thrombosis – experts doubt study
First report from Tuesday, March 23rd, 2021, 3:50 p.m .: Kassel – For those viewed critically by the population and in the media Corona vaccine of the British-Swedish pharmaceutical company Astrazeneca there is positive news. A USstudy, which was published on Monday (March 22nd, 2021) comes to the conclusion that the Vaccine is very effective in the elderly.
Accordingly, the shows Astrazeneca vaccine a 79 percent effectiveness in preventing symptomatic Corona diseases. In addition, that should VaccineAs the company announced, it could even be 100 percent suitable for preventing the course of serious illness and avoiding hospital stays.
Astrazeneca: New study aims to refute increased risk of thrombosis
In addition, the doubts about the formation of blood clots after a Corona vaccination been scattered. According to the experts, it works vaccine in all age groups. This effect was with previous ones Studies has not been determined.
At the study to the Corona vaccine Astrazeneca took about 32,500 subjects in the US, Chile and Peru shares. Two thirds of them were vaccinated. Around 20 percent of the participants were 65 years of age or older and around 60 percent had previous illnesses such as diabetes, which placed the risk of a severe course Covid-19 disease increase. A heightened one Risk of thrombosis was not found in the 21,583 subjects who received at least one vaccine dose.
Astrazeneca study: experts question results and data used
The U.S. Department of Health NIAID now has doubts about the informative value of the data from the pharmaceutical company’s new study Astrazeneca to its vaccine voiced. According to the US experts, the company could with their study have used outdated data.
“The DSMB has expressed concern that Astrazeneca may have included outdated information from this study, which could have provided an incomplete view of the efficacy data, “said the National Institute for Infectious Diseases (NIAID) on Monday (March 22nd, 2021), citing the Data and Safety Monitoring Board (DSMB) .
After two deaths: Denmark continues to stop using Astrazeneca
In Denmark, the use of Astrazeneca’s vaccine is still suspended after two new cases of severe disease on Saturday (March 20th, 2021) Thrombosis were reported to have been vaccinated with Astrazeneca occurred. That reports the Spiegel and refers to the Danish media. First the Danish newspaper had Extra Bladet reported on the two cases.
It is said to have been two employees of a hospital. The Danish Medicines Agency confirmed according to the Spiegel both cases on Twitter, but gave no further details. According to the Danish media, a victim apparently died as a result of one Hirnthrombose. Extra Bladet reports that one of the two people is said to be a 30-year-old woman. Both hospital employees were said to be less than 14 days before the onset of Symptoms with the Astrazeneca vaccine have been vaccinated.
Is Astrazeneca’s vaccine effective enough on corona mutants?
Astrazeneca is in Germany inoculated again. Still, some people and medical professionals agree Vaccine critical of. Now the message provides further material for discussion, various Vaccines be against them Corona variants not effective enough – that also reports merkur.de *. The development of herd immunity is no longer possible.
Astrazeneca shows, for example, towards the South African mutant a comparatively small effect. Also the vaccines from Johnson & Johnson and Novavax, which is currently under review by the European Medicines Agency (EMA), have, according to a contribution from Deutschlandfunk with variant B.1.351 only a reduced effectiveness of 50 to 60 percent.
A chief neurologist from Hessen comments on corona vaccines that he should have voted for Astrazeneca decided. But how do they work? Corona vaccines? These are the differences between Astrazeneca *, Biontech and Co. (Helena Gries and Sandra Böhm) * merkur.de and echo24.de are offers from IPPEN.MEDIA.
Headline list image: © Gareth Fuller / dpa